Clinical Trials List
Protocol Number42756493LUC2001
Completed
2016-03-01 - 2024-11-28
Phase II
Terminated1
-
Trial Applicant
Johnson & Johnson
-
Sponsor
-
Trial scale
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- 陳彥豪 Division of Hematology & Oncology
- 黃泰霖 Division of Hematology & Oncology
- Tai-Jan Chiu Division of Hematology & Oncology
- 歐信佑 Division of Radiology
- Shau-Hsuan Li Division of Hematology & Oncology
- Yu-Li Su Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
10 participants
-
Global
90 participants
